Aprogen Pharmaceuticals Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Aprogen Pharmaceuticals Inc with three other
companies in this sector in KOREA (SOUTH) :
Seoul Pharma Co., Ltd.
sales of 52.23 billion Korean Won [US$46.70 million]
Jin Yang Pharmaceuticals Co Ltd
(48.81 billion Korean Won [US$43.64 million]
of which 100%
was medicine and medical supplies), and
Sam-A Pharmaceutical Company
(53.65 billion Korean Won [US$47.97 million]
of which 53%
was Finished Goods-Respiratory machine).
During the first
quarter of 2021, sales at Aprogen Pharmaceuticals Inc totalled
12.28 billion Korean Won .
This is a drop of 11.3%
from the 13.84 billion Korean Won in sales at the company during the first quarter in 2020.
During the year ended December of 2020, sales at
Aprogen Pharmaceuticals Inc were 53.32 billion Korean Won (US$47.67 million).
increase of 4.7%
versus 2019, when the company's sales were 50.90 billion Korean Won .